{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:59:37Z","timestamp":1762433977568,"version":"build-2065373602"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Due to their rarity and complexity sarcomas require specialized multidisciplinary team management. COVID-19 pandemic brought to a rapid implementation of telemedicine and activation of digital tools. This study evaluates the perception of virtual disease multidisciplinary team among healthcare professionals of an European rare cancer referral center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An online survey was administered to the participants of Regina Elena National Cancer Institute\u2019s Sarcoma disease multidisciplinary team meetings held between 2020 and 2022. It was composed of 40 questions comparing face-to-face and virtual meetings. Data from the Institutional disease multidisciplinary team from 2019 to 2022 were also analyzed retrospectively to compare the pre-covid, covid, and post-covid phases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-two healthcare professionals answered the survey. In their opinion, decision-making process was not affected by virtual modality (86.0%). Regarding virtual meetings 90.0% were highly\/moderately satisfied with depth of discussion, 95.0%\u2013100% were able to interact adequately and access all relevant data. The most important improvements of virtual disease multidisciplinary team were better quality of clinical approach\/research (22.7%\u201331.8%), technological innovations (50.0%), and logistical setting (95.5%). 90.0% to 100% thought that virtual disease multidisciplinary team could be approved thereafter. We observed an increase in participation rate from 58.0, to 62.0%, to 64.0% (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0159) and a rise in the new cases discussed at meetings compared to the re-discussed ones from 30.1% to 37.9% to 42.3% (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.0001) in the pre-covid, covid, and post-covid phases, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Virtual disease multidisciplinary team enhances participation and discussion quality without compromising patient care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1636095","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:54:34Z","timestamp":1762433674000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Virtual sarcoma disease multidisciplinary team: a successful experience in the era of telemedicine and COVID-19 in Italy"],"prefix":"10.3389","volume":"13","author":[{"given":"Francesca","family":"Salvatori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta Elisa","family":"Onesti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Vari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Ceddia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Checcucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Cosimati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Riva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Renna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Ferraresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"key":"ref2","article-title":"Soft tissue and bone tumours","volume-title":"WHO classification of tumours","author":"Fletcher","year":"2020"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ejca.2012.09.011","article-title":"Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project","volume":"49","author":"Stiller","year":"2013","journal-title":"Eur J Cancer"},{"key":"ref4","year":"2023"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/S1470-2045(12)70361-3","article-title":"Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits","volume":"13","author":"Brasme","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.annonc.2021.06.007","article-title":"Deep learning for diagnosis and survival prediction in soft tissue sarcoma","volume":"32","author":"Foersch","year":"2021","journal-title":"Ann Oncol"},{"key":"ref7","year":"2021"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"iv79","DOI":"10.1093\/annonc\/mdy310","article-title":"Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"iv51","DOI":"10.1093\/annonc\/mdy096","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"ref10","year":"2024"},{"key":"ref11","year":"2022"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1186\/s12913-022-08112-0","article-title":"Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review","volume":"22","author":"Walvaer","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"ref13","year":"2016"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s41030-021-00163-8","article-title":"Virtual multidisciplinary tumor boards: a narrative review focused on lung Cancer","volume":"7","author":"Gebbia","year":"2021","journal-title":"Pulm Ther"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.3390\/cancers13164159","article-title":"The effects of multidisciplinary team meetings on clinical practice for colorectal, lung, prostate and breast cancer: a systematic review","volume":"13","author":"Ko\u010do","year":"2021","journal-title":"Cancers"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"102032","DOI":"10.1016\/j.ejon.2021.102032","article-title":"Exploring the impact of uro-oncology multidisciplinary team meetings on patient outcomes: a systematic review","volume":"54","author":"Askelin","year":"2021","journal-title":"Eur J Oncol Nurs"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1245\/s10434-016-5178-3","article-title":"Is there a benefit of multidisciplinary cancer team meetings for patients with gastrointestinal malignancies?","volume":"23","author":"Basta","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.healthpol.2014.09.006","article-title":"Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes","volume":"119","author":"Prades","year":"2015","journal-title":"Health Policy"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3390\/jcm9061868","article-title":"Reorganization tips from a sarcoma unit at time of the COVID-19 Pandemie in ltaly: early experience from a regional referral oncologic center","volume":"9","author":"Rossi","year":"2020","journal-title":"J Clin Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1000056","DOI":"10.3389\/fonc.2022.1000056","article-title":"The impact of the COVID-19 pandemic on diagnosis and treatment of patients with soft tissue and bone sarcomas or aggressive benign musculoskeletal diseases: a single-center retrospective study (SarCorD study)","volume":"12","author":"Onesti","year":"2022","journal-title":"Front Oncol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1078992","DOI":"10.3389\/fpsyg.2023.1078992","article-title":"Quality of life and emotional distress in sarcoma patients diagnosed during COVID-19 pandemic: a supplementary analysis from the SarCorD study","volume":"14","author":"Onesti","year":"2023","journal-title":"Front Psychol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1200\/GO.20.00351","article-title":"Impact of the COVID-19 pandemic on cancer care: a global collaborative study","volume":"6","author":"Jazieh","year":"2020","journal-title":"JCO Glob Oncol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"100157","DOI":"10.1016\/j.esmoop.2021.100157","article-title":"Impact of the COVID-19 pandemic on the care of cancer patients in Spain","volume":"6","author":"Amador","year":"2021","journal-title":"ESMO open"},{"key":"ref24","volume-title":"What are relevant, feasible and effective approaches to promote acceptance, uptake and adherence to physical distancing measures for COVID-19 prevention and control?","author":"Rebecca","year":"2021"},{"key":"ref25","year":""},{"key":"ref26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12891-020-03925-8","article-title":"Will virtual multidisciplinary team meetings become the norm for musculoskeletal oncology care following the COVID-19 pandemic? - experience from a tertiary sarcoma Centre","volume":"22","author":"Rajasekaran","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1007\/s00330-022-09083-w","article-title":"Attitudes and perceptions of radiologists towards online (virtual) oncologic multidisciplinary team meetings during the COVID-19 pandemic-a survey of the European Society of Oncologic Imaging (ESOI)","volume":"33","author":"Bonanno","year":"2022","journal-title":"Eur Radiol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1636095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:54:35Z","timestamp":1762433675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1636095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":27,"alternative-id":["10.3389\/fpubh.2025.1636095"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1636095","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"article-number":"1636095"}}